GMALL-BLIVEN

Hematological neoplasms
Acute lymphoblastic leukemia
Follow-Up Treatment
Venetoclax in addition to Venetoclax in addition to Blinatumomab immunotherapy in adult patients with relapsed/refractory B cell precursor acute lymphoblastic leukemia (BCP-ALL)
Venetoclax in addition to Venetoclax in addition to Blinatumomab immunotherapy in adult patients with relapsed/refractory B cell precursor acute lymphoblastic leukemia (BCP-ALL)